High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up-Reference-Cited by-同舟云学术

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up

Published:2006-04-01 Issue:2 Volume:8 Page:183-188
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Abrey Lauren E.,Childs Barrett H.,Paleologos Nina,Kaminer Lynne,Rosenfeld Steven,Salzman Donna,Finlay Jonathan L.,Gardner Sharon,Peterson Kendra,Hu Wendy,Swinnen Lode,Bayer Robert,Forsyth Peter,Stewart Douglas,Smith Anne M.,Macdonald David R.,Weaver Susan,Ramsay David A.,Nimer Stephen D.,Deangelis Lisa M.,Cairncross J. Gregory

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/8/2/183/13066311/NO82_11_Abrey.pdf

Reference16 articles.

1. Abrey, L.E., Childs, B.H., Paleologos, N., Kaminer, L., Rosenfeld, S., Salzman, D., Finlay, J.L., Gardner, S., Peterson, K., Hu, W., Swinnen, L., Bayer, R., Forsyth, P., Stewart, D., Smith, A.M., Macdonald, D.R., Weaver, S., Ramsey, D.A., Nimer, S.D., DeAngelis, L.M., and Cairncross, J.G. (2003) High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. J. Neurooncol.65, 127-134.

2. Cairncross, J.G., and Macdonald, D.R. (1991) Chemotherapy for oligodendroglioma. Arch. Neurol.48, 225-227.

3. Cairncross, J.G., Macdonald, D.R., Ludwin, S., Lee, D., Cascino, T., Buckner, J., Fulton, D., Dropcho, E., Stewart, D., and Schold, C., Jr. (1994) chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol.12, 2013-2021.

4. Cairncross, J.G., Ueki, K., Zlatescu, M.C., Lisle, D.K., Finkelstein, D.M., Hammond, R.R., Silver, J.S., Stark, P.C., Macdonald, D.R., Ino, Y., Ramsay, D.A., and Louis, D.N. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst.90, 1473-1479.

5. Cairncross, J.G., Seiferheld, W., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L., and Curran, W. (2004) An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94-02. J. Clin. Oncol.22 (suppl.), 197 (abstract 1500).

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligodendroglioma: A Review of Management and Pathways;Frontiers in Molecular Neuroscience;2021-10-05

2. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade;Journal of Neuro-Oncology;2018-12-18

3. Marrow-Ablative Chemotherapy With Autologous Hematopoietic Progenitor Cell Rescue in Brain Tumors;Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy;2018

4. Low-Grade Gliomas;Principles of Neurological Surgery;2018

5. Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma;Neuro-Oncology;2017-05-02